Herpes virus in Alzheimer's disease: relation to progression of the disease
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Self-citationInitiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Self-citationNaj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 1×
“2009; Hollingworth et al., 2011; Lambert et al., 2009; Naj et al., 2011).”
Self-citationFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques
Wozniak, M., Mee, A., & Itzhaki, R. (2009) · The Journal of Pathology · doi:10.1002/path.2449 · Cited by 464
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
Krstic, D., Madhusudan, A., Doehner, J., Vogel, P., Notter, T., Imhof, C., Manalastas, A., Hilfiker, M., Pfister, S., Schwerdel, C., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-151 · Cited by 400
The Influence of Latent Viral Infection on Rate of Cognitive Decline over 4 Years
Aiello, A. E., Haan, M. N., Blythe, L., Moore, K., Gonzalez, J. M., & Jagust, W. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00796.x · Cited by 210 · cited 2×
“Our findings are in accordance with another report showing an association between elevated CMV IgG and cognitive deterioration in elderly individuals followed up for 4 years (Aiello et al., 2006).”
BackgroundResultBlood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging
Ravaglia, G., Forti, P., Maioli, F., Chiappelli, M., Montesi, F., Tumini, E., Mariani, E., Licastro, F., & Patterson, C. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.012 · Cited by 198 · cited 2×
“…has been associated with cognitive impairment and AD; for instance, increased blood levels of cytokines and acute phase protein such as a1-antichimotripsin were also correlated with age-associated cognitive impairment and AD (Licastro et al., 2010b; Porcellini et al., 2008; Ravaglia et al., 2007).”
BackgroundSelf-citation
Research works printed but not linked: 34
- Burgos, 2006, Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA, J. Virol., 80, 5383, 10.1128/JVI.00006-06 · DOI · Paper page
- Carter, 2008, Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: Relevance to pathological-signalling cascades, Neurochem. Int., 52, 920, 10.1016/j.neuint.2007.11.003 · DOI
- Corey-Bloom, 2000, E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease, Neurology, 54, 403, 10.1212/WNL.54.2.403 · DOI · Paper page
- Fenner, 1991, Diagnosis of human cytomegalovirus-induced retinitis in human immunodeficiency virus type 1- infected subjects by using the polymerase chain reaction, J. Clin. Microbiol., 29, 2621, 10.1128/JCM.29.11.2621-2622.1991 · doi:10.1128/jcm.29.11.2621-2622.1991
- Forti, 2001, Conselice study: a population based survey of brain aging in a municipality of the Emilia Romagna region (A.U.S. L. Ravenna). Neuropsychological tests and nutritional status, Arch. Gerontol. Geriatr. Suppl., 7, 137, 10.1016/S0167-4943(01)00132-7 · doi:10.1016/s0167-4943(01)00132-7
- Gerna, 2004, Pathogenesis of human cytomegalovirus infection and cellular targets [review], Hum. Immunol., 65, 381, 10.1016/j.humimm.2004.02.009 · DOI
- Hansen, 1993, Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa, J. Neuropathol. Exp. Neurol., 52, 648, 10.1097/00005072-199311000-00012 · DOI · Paper page
- Hemling, 2003, Herpesviruses in brains in Alzheimer's and Parkinson's diseases, Ann. Neurol., 54, 267, 10.1002/ana.10662 · DOI · Paper page
- Itzhaki, 2004, Infiltration of the brain by pathogens causes Alzheimer's disease [review], Neurobiol. Aging, 25, 619, 10.1016/j.neurobiolaging.2003.12.021 · DOI · Paper page
- Itzhaki, 2008, Herpes simplex virus type 1 in Alzheimer's disease: the enemy within, J. Alzheimers Dis., 13, 393, 10.3233/JAD-2008-13405 · DOI · Paper page
- Kleines, 2011, Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity, Eur. J. Clin. Microbiol. Infect. Dis., 30, 1561, 10.1007/s10096-011-1261-7 · DOI
- Koch, 2006, Human cytomegalovirus infection and T cell immunosenescence: a mini review, Mech. Ageing Dev., 127, 538, 10.1016/j.mad.2006.01.011 · DOI
- Kutok, 2006, Spectrum of Epstein-Barr virus-associated diseases, Annu. Rev. Pathol., 1, 375, 10.1146/annurev.pathol.1.110304.100209 · DOI · Paper page
- Lang, 2012, Reversing T cell immunosenescence: why, who, and how, Age (Dordr)
- Lassmann, 2011, Epstein-Barr virus in the multiple sclerosis brain: a controversial issue—report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria, Brain, 134, 2772, 10.1093/brain/awr197 · DOI · Paper page
- Licastro, 1999, Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease, Neurosci. Lett., 270, 129, 10.1016/S0304-3940(99)00468-1 · DOI
- Licastro, 2007, Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation, Neurobiol. Aging, 28, 1637, 10.1016/j.neurobiolaging.2006.07.007 · DOI
- Licastro, 2010, Gene-gene and gene—clinical factors interaction in acute myocardial infarction: a new detailed risk chart, Curr. Pharm. Des., 16, 783, 10.2174/138161210790883543 · DOI
- Licastro, 2010, Multi factorial interactions in the pathogenesis pathway of Alzheimer's disease: a new risk charts for prevention of dementia, Immun. Ageing, 7, S4, 10.1186/1742-4933-7-S1-S4 · DOI
- Licastro, 2011, Gene signature in Alzheimer's disease and environmental factors: the virus chronicle, J. Alzheimers Dis., 27, 809, 10.3233/JAD-2011-110755 · DOI · Paper page
- Lin, 2002, Herpesviruses in brain and Alzheimer's disease, J. Pathol., 197, 395, 10.1002/path.1127 · DOI · Paper page
- Malorny, 2003, Multicenter validation of the analytical accuracy of Salmonella PCR: towards an international standard, Appl. Environ. Microbiol., 69, 290, 10.1128/AEM.69.1.290-296.2003 · DOI · Paper page
- McKahnn, 1984, Clinical diagnosis of Alzheimer's disease: report of NINCDSADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheimer's disease, Neurology, 34, 934
- Mori, 2004, Reactivation of HSV-1in the brain of patients with familial Alzheimer's disease, J. Med. Virol., 73, 605, 10.1002/jmv.20133 · DOI · Paper page
- Pawelec, 2009, Cytomegalovirus and human immunosenescence, Rev. Med. Virol., 19, 47, 10.1002/rmv.598 · DOI · Paper page
- Porcellini, 2008, Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target, Curr. Pharm. Des., 14, 2659, 10.2174/138161208786264151 · DOI
- Porcellini, 2010, Alzheimer's disease gene signature says: beware of brain viral infections, Immun. Ageing, 7, 16, 10.1186/1742-4933-7-16 · DOI · Paper page
- Ravaglia, 2001, Conselice study: a population based survey of brain aging in a municipality of the Emilia Romagna region (A.U.S.L. Ravenna). Design and methods, Arch. Gerontol. Geriatr. Suppl., 7, 313, 10.1016/S0167-4943(01)00155-8 · DOI
- Rymkiewicz, 2012, The immune system in the aging human, Immunol. Res., 53, 235, 10.1007/s12026-012-8289-3 · DOI
- Simanek, 2011, Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States, PLoS One, 17, e16103, 10.1371/journal.pone.0016103 · DOI · Paper page
- Tsutsui, 2008, Roles of neural stem progenitor cells in cytomegalovirus infection of the brain in mouse models [review], Pathol. Int., 58, 257, 10.1111/j.1440-1827.2008.02221.x · DOI
- Vogl, 2012, Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation, J. Med. Virol., 84, 119, 10.1002/jmv.22258 · doi:10.1002/jmv.22258
- Wakefield, 1992, Detection of Herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction, J. Med. Virol., 38, 183, 10.1002/jmv.1890380306 · DOI · Paper page
- Yao, 2010, Review part 2: human herpesvirus-6 in central nervous system diseases, J. Med. Virol., 82, 1669, 10.1002/jmv.21861 · DOI · Paper page
Cited by
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Readhead, B., Haure-Mirande, J.-V., Funk, C. C., Richards, M. A., Shannon, P., Haroutunian, V., Sano, M., Liang, W. S., Beckmann, N. D., Price, N. D., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.023 · Cited by 708
“, 2002) and seroprevalence (Carbone et al., 2014), though subsequent serological studies did not find increased HHV-6 seropositivity (Agostini et al.”
BackgroundThe Infectious Etiology of Alzheimer’s Disease
Sochocka, M., Zwolińska, K., & Leszek, J. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170313122937 · Cited by 399
Harris, S. A., & Harris, E. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142853 · Cited by 279
“The same researchers found that baseline EBV DNA positive PBLs and serum IgG levels for EBV antigens were significantly increased in a group of elderly individuals who developed AD during a subsequent 5-year followup period [85].”
BackgroundMethodUnger, M. S., Li, E., Scharnagl, L., Poupardin, R., Altendorfer, B., Mrowetz, H., Hutter-Paier, B., Weiger, T. M., Heneka, M. T., Attems, J., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.070 · Cited by 248
Early neuronal accumulation of DNA double strand breaks in Alzheimer’s disease
Shanbhag, N. M., Evans, M. D., Mao, W., Nana, A. L., Seeley, W. W., Adame, A., Rissman, R. A., Masliah, E., & Mucke, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0723-5 · Cited by 214
“(PDF 11500 kb) Abbreviations AD: Alzheimer’s disease; Aβ: Amyloid-β; Bic: Bicuculline; Ctl: Control; DAB: Diaminobenzidine; DI-PLA: DNA damage in situ ligation followed by proximity ligation assay; DSBs: DNA double strand breaks; ETP: Etoposide; FITC: Fluorescein isothiocyanate; HHV6: Human herpesvirus 6; HRP: Horsera…”
Self-citationThe Possibility of an Infectious Etiology of Alzheimer Disease
Ashraf, G. M., Tarasov, V. V., Makhmutovа, A., Chubarev, V. N., Avila-Rodriguez, M., Bachurin, S. O., & Aliev, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1388-y · Cited by 175
Time to test antibacterial therapy in Alzheimer’s disease
Panza, F., Lozupone, M., Solfrizzi, V., Watling, M., & Imbimbo, B. P. (2019) · Brain · doi:10.1093/brain/awz244 · Cited by 161
Herpes Viruses Increase the Risk of Alzheimer’s Disease: A Meta-Analysis
Steel, A. J., & Eslick, G. D. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-140822 · Cited by 154
Warren-Gash, C., Forbes, H. J., Williamson, E., Breuer, J., Hayward, A. C., Mavrodaris, A., Ridha, B. H., Rossor, M. N., Thomas, S. L., & Smeeth, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-41218-w · Cited by 125
Infectious agents and Alzheimer's disease
Piekut, T., Hurła, M., Banaszek, N., Szejn, P., Dorszewska, J., Kozubski, W., & Prendecki, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102073 · Cited by 123
Human Herpesvirus 6 Detection in Alzheimer’s Disease Cases and Controls across Multiple Cohorts
Allnutt, M. A., Johnson, K., Bennett, D. A., Connor, S. M., Troncoso, J. C., Pletnikova, O., Albert, M. S., Resnick, S. M., Scholz, S. W., De Jager, P. L., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.031 · Cited by 119
Nimgaonkar, V. L., Yolken, R. H., Wang, T., Chang, C.-C. H., McClain, L., McDade, E., Snitz, B. E., & Ganguli, M. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000133 · Cited by 109
Lövheim, H., Olsson, J., Weidung, B., Johansson, A., Eriksson, S., Hallmans, G., & Elgh, F. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161305 · Cited by 103
“[15] reported that 55 persons who developed AD over a 5-year period 56 presented with increased anti-CMV immunoglobu57 lin (Ig) G levels at baseline.”
López González, I., Garcia-Esparcia, P., Llorens, F., & Ferrer, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020206 · Cited by 101
“Infectious burden of cytomegalovirus, herpes virus 1, Borrelia burgdorferi, Chlamydophila pneumonia, and Helicobacter pylori is associated with AD [93–98].”
BackgroundVojtechova, I., Machacek, T., Kristofikova, Z., Stuchlik, A., & Petrasek, T. (2022) · PLOS Pathogens · doi:10.1371/journal.ppat.1010929 · Cited by 92
Herpesvirus infections and Alzheimer's disease: a mendelian randomization study
Huang, S.-Y., Yang, Y.-X., Kuo, K., Li, H.-Q., Shen, X.-N., Chen, S.-D., Cui, M., Tan, L., Dong, Q., & Yu, J.-T. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00905-5 · Cited by 82
The Role of Human Herpesvirus 6 Infection in Alzheimer’s Disease Pathogenicity—A Theoretical Mosaic
Romanescu, C., Schreiner, T. G., & Mukovozov, I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113061 · Cited by 24
“[19], who report that peripheral blood leucocytes showed a significant association between HHV-6 DNA in the periphery and HHV-6 level in the brains of AD patients, thus strengthening the argument in favor of an association between AD and HHV-6.”
ResultOnisiforou, A., & Spyrou, G. M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab141 · Cited by 23
Wang, Y., Luo, W., Wang, X., Ma, Y., Huang, L., & Wang, Y. (2022) · Journal of Infection · doi:10.1016/j.jinf.2021.12.004 · Cited by 17
Metadata
- Authors
- Carbone, I., Lazzarotto, T., Ianni, M., Porcellini, E., Forti, P., Masliah, E., Gabrielli, L., & Licastro, F.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 35
- Issue
- 1
- Pages
- 122-129
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W1981063899
- Cited by
- 211
- References
- 10
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Italian Ministry for University and Research
- CARISBO Foundation Bologna
- BRACCO Pharmaceutics Milano
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.